Newly launched aggregator Seqster will help Boston University researchers collect data from EHRs, wearables, and gene tests to identify concussion biomarkers.
The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma.
The company will develop the assays for its single-molecule array technology and incorporate the markers into multiplex assays for research use in neurology.
The firm is investing in studies that use its multiplex microarray platform to monitor lupus disease activity and traumatic brain injury response.
The firm will look for metabolic profiles that could help diagnose asphyxia in human newborns, signatures that were derived from animal studies.
The firms said their test will be developed to detect levels of the tau protein that can leak into a person's bloodstream after head trauma or injury.
The grant is being provided under the NIH's Extracellular RNA Communication program, which was set up to study the role of molecules such as microRNAs.
Researchers sequenced the genome of Spirometra erinaceieuropaei with DNA from tapeworm that had been living in the patient's brain for several years.
This article has been updated to include ImmunArray's participation in the program.
NEW YORK (GenomeWeb News) – The National Institute of Nursing Research plans to fund research projects that seek to uncover genomic variants or mechanisms that are involved in how patients respond to rehabilitation efforts, NINR said today.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.
Futurism writes that gene doping could be the next generation of cheating in sports.